June 2024 in “International Journal of Pharmaceutical Research and Applications” This study designed fast-dissolving Minoxidil tablets to improve patient compliance and found that formulations containing 6% croscarmellose sodium were optimal, showing rapid in-vitro dispersion and effective drug release without drug interaction.
May 2019 in “International Journal of Research In Pharmaceutical Chemistry and Analysis” This study developed and validated a UV spectrophotometric method for accurately estimating Minoxidil in tablet form, showing linearity across concentrations from 1-6µg/ml.
September 2024 in “Journal of Clinical and Nursing Research” This study found that combining Chuzhi Shengfa Tablets with either ketoconazole shampoo or 5% minoxidil foam significantly improved hair density, hair diameter, and reduced scalp oil in men with androgenetic alopecia, without increasing adverse reactions.
September 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” This study found that combining minoxidil with platelet-rich plasma and basic fibroblast growth factor was the most effective treatment for increasing hair density in androgenetic alopecia, showing a significant improvement over minoxidil alone.
June 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” This systematic review and meta-analysis found that oral minoxidil may improve hair loss symptoms, with 35% of patients experiencing significant symptom improvement, but further research is needed to confirm its efficacy and safety, especially at doses exceeding 1 mg.
